Alzheimer's disease clinical trials success rate globally from 2008-2019, by phase

This statistic depicts the success rate of Alzheimer's disease clinical trials globally, compared to other drugs, from 2008 to 2019, by phase. During that time, 57 percent of trials for all diseases were successful in phase III, while none of the Alzheimer's disease clinical trials were successful during phase III.

Probability of success for Alzheimer's drug clinical trials worldwide from 2008 to 2019, by phase

All diseasesAlzheimer's disease
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2019

Region

Worldwide

Survey time period

Data from January 2008 to February 2019

Supplementary notes

Data for Alzheimer’s Disease is based on approximately 139 drug program transitions in the Biomedtracker database.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Alzheimer's and other dementias"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.